Alisa Berger Examines Universal Health Care Feasibility
In a recent essay published on Kevin MD, urologist Alisa Berger examines the feasibility and economic rationale of implementing universal health care in the United States, framing the debate around public policy, government function, and the legacy of Dolly Parton.
-
Key Clinical Takeaways:
- The United States spent $5.3 trillion on health care in 2024, translating to $15,474 per capita, which represents a 7.2 percent increase outpacing gross domestic product growth.
- An estimated 37 million Americans lack health insurance, while an additional 41 million live with inadequate coverage or access.
- Economic evaluations cited in the essay project that a single-payer universal health care model could yield significant national health expenditure savings, though federal tax commitments would rise.
Economic Realities of American Health Expenditures
The essay highlights that national health expenditures in the United States reached $5.3 trillion, or $15,474 per individual, during 2024. This spending level marks a 7.2 percent increase that outpaced general economic growth, which stood at 5.3 percent. Federal allocations toward national health expenditures are projected to climb from 31 percent, equating to more than $1.6 trillion in 2024, to 33 percent by the year 2034.
Despite these high expenditures, coverage gaps persist across the population. Thirty-seven million individuals remain entirely uninsured, and another 41 million experience inadequate health coverage or limited access to necessary medical services. The author points out that the United States remains the sole wealthy, industrialized nation without a universal health care model, grouping the country’s coverage metrics alongside developing nations such as Mexico, Somalia, and the Democratic Republic of Congo.
Projections on Cost Savings and Universal Coverage Models
Evaluating the financial impact of structural reform, the essay references a 2020 study indicating a 13 percent reduction—amounting to $450 billion—in national health expenditures under a single-payer framework. A subsequent review from July 2026 suggests potential annual savings of $1 trillion alongside the prevention of 114,000 deaths each year.
Additional context is drawn from a 2018 analysis by the Mercatus Center, which estimated total expenditure savings of $318 billion. However, that analysis noted that federal financial commitments would simultaneously rise, necessitating adjustments in federal taxation or debt. Conversely, alternative policy arguments suggest that universal systems can be sustained using existing government funding streams combined with current employer and household premiums. The essay notes that under such a transition, a typical middle-class family could save $4,400 annually, while businesses could experience average savings of $9,000 per employee.
Regulatory Oversight Must Overcome Public Skepticism and Fear
Addressing common hesitations regarding government involvement, the essay acknowledges public skepticism stemming from experiences with institutions like VA hospitals, which are frequently associated with extended wait times. The author argues that these concerns, while valid, should be addressed by removing special interest influence and lobbying from for-profit insurance and pharmaceutical entities rather than rejecting regulatory oversight outright.
The writing contends that political discourse often utilizes fear—regarding socialism, gender identity, or Islam—to deter practical policy development. Defining government by its fundamental function to perform necessary societal duties, the urologist asserts that providing a baseline of health services constitutes both a moral and an economic imperative for an industrialized nation.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.